The global Epigenetics
Market size is expected to reach USD 39.15
billion by 2030, registering a CAGR of 15.3% from 2024 to 2030, according to a
new report by Grand View Research, Inc. The market is being driven by factors,
such as the rise in funding, investment & regulatory approvals for
epigenetics research & development, the expansion of the use of epigenetic
enzymes in drug discovery & development, and the decreasing cost of genome
sequencing. Since epigenetics has demonstrated beneficial applications outside
of cancer, commercial expansion is envisaged. The rising demand for
understanding epigenetic alterations at the molecular level, as well as the
advancement of medicinal treatments, would likely push these
organizations to support research and development programs.
Furthermore, initiatives, such as the
Epidemiology and Genomics Research Program (EGRP), provide incentives for
research efforts aimed at better-comprehending cancer genesis and consequences.
A few organizations that help fuel the market's rise are the International
Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the
National Institutes of Health (NIH). These organizations support funding and
help for initiatives involving product development and R&D in the field of
epigenetics. For instance, the National Institutes of Health aggressively
promotes cutting-edge epigenetic research worldwide through its common fund
epigenomics program.
Request a
free sample copy or view report summary: Epigenetics
Market Report
Epigenetics
Market Report Highlights
·
By product, the reagents segment dominated
the industry, accounting for 33.45% of the global revenue in 2023. The large
share of this segment can be attributed to the high usage of reagents in
epigenetic research studies.
·
By technology, the DNA methylation segment
dominated the market with a revenue share of 45.36% in 2023. DNA methylation's
demand in epigenetics stems from its pivotal role in gene expression
regulation.
·
By application, the oncology segment
dominated the market with a revenue share of 69.06% in 2023. Oncology's demand
for epigenetics arises from the intricate relationship between epigenetic
alterations and cancer development.
·
North America dominated the market and
accounted for a 38.19% share in 2023. The region experiences growth due to
heightened public awareness, robust medical facilities, and substantial R&D
investments.
Epigenetics
Market Segmentation
Grand View Research has segmented the
global epigenetics market on the basis of product, technology, application,
end-use, and region:
Epigenetics Product Outlook (Revenue,
USD Million, 2018 - 2030)
·
Reagents
·
Kits
o ChIP sequencing kit
o Whole Genomic Amplification kit
o Bisulfite Conversion kit
o RNA sequencing kit
o Others
·
Instruments
·
Enzymes
·
Services
Epigenetics Technology Outlook
(Revenue, USD Million, 2018 - 2030)
·
DNA Methylation
·
Histone Methylation
·
Histone Acetylation
·
Large non-coding RNA
·
MicroRNA modification
·
Chromatin structures
Epigenetics Application Outlook
(Revenue, USD Million, 2018 - 2030)
·
Oncology
o Solid tumors
o Liquid tumors
·
Non-oncology oncology
o Inflammatory diseases
o Metabolic diseases
o Infectious diseases
o Cardiovascular diseases
o Others
Epigenetics End-use Outlook (Revenue,
USD Million, 2018 - 2030)
·
Academic Research
·
Clinical Research
·
Hospitals & Clinics
·
Pharmaceutical & Biotechnology
Companies
·
Other Users
Epigenetics Regional Outlook (Revenue,
USD Million, 2018 - 2030)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
·
Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Thailand
·
Latin America
o Brazil
o Mexico
o Argentina
·
MEA
o South Africa
o Saudi Arabia
o UAE
o Kuwait
List of Key Players of Epigenetics
Market
·
Roche Diagnostics
·
Thermo Fisher Scientific, Inc.
·
Eisai Co. Ltd.
·
Novartis AG
·
Element Biosciences, Inc.
·
Dovetail Genomics LLC.
·
Illumina, Inc.
·
Promega Corporation.
·
Abcam plc.
About Us
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment